Position in ELAN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$14,175
+$2,761 QoQ
Shares Held
576
+20.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#32
of 52 holders
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026True Wealth Design, LLC holds $493,263 across 27 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
1,064 | $179,326 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
162 | $87,776 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,638 | $58,317 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
687 | $43,933 | |
| 5 | PRGO |
PERRIGO Co plc
|
1,498 | $15,564 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
431 | $14,602 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
576 | $14,175 | |
| 8 | ZTS |
Zoetis Inc.
|
166 | $11,928 |
All Filings in ELAN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,175 | 576 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $11,414 | 477 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $11,224 | 496 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $6,404 | 318 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $428 | 30 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,667 | 254 | Shares | Sole | 2025-05-13 | |
| 2022-12-31 | $97 | 8 | Shares | Sole | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||